Meitav Investment House’s NEVRO CORP. NVRO Stock Holding History

Meitav Investment House’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,000	Closed	-$263K	–	482
2019 Q3	$263K	Buy	+3,000	New	+$227K	0.02%	362
2019 Q2	–	Sell	-11,000	Closed	-$680K	–	496
2019 Q1	$680K	Sell	11,000 -8,000	-42%	-$376K	0.04%	206
2018 Q4	$715K	Buy	19,000 +3,300	+21%	+$147K	0.04%	178
2018 Q3	$902K	Sell	15,700 -6,600	-30%	-$413K	0.04%	218
2018 Q2	$1.75M	Buy	22,300 +17,300	+346%	+$1.44M	0.08%	128
2018 Q1	$433K	Buy	+5,000	New	+$404K	0.02%	266

Other funds holding NVRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Meitav Investment House's NVRO Position: Q4 2019 in Review

Meitav Investment House sold out of NEVRO CORP. (NVRO) in Q4 2019, closing a stake of 3,000 shares — an estimated $263K sold.

Meitav Investment House first reported a position in NVRO in Q1 2018 and held it in 6 quarters. The position peaked at $1.75M in Q2 2018. 191 funds tracked by Wall St. Rank hold NVRO as of Q4 2019.

Meitav Investment House reported no remaining NEVRO CORP. position as of Q4 2019 after selling out during the quarter.
Meitav Investment House sold 3,000 NEVRO CORP. shares in Q4 2019, an estimated $263K.
Meitav Investment House first reported a position in NEVRO CORP. in Q1 2018 and held it in 6 quarters.
Meitav Investment House's NEVRO CORP. position peaked at $1.75M in Q2 2018.
191 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2019.

Based on Meitav Investment House's 13F filing for Q4 2019, filed 10 Feb 2020.